Skip Nav Destination
PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies
Mol Cancer Ther (2021) 20 (7): 1270–1282.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Wanru Ma
- Junhua Hu
Genes & Genomics (2024) 46 (6): 713.
- Ryuto Tomabechi
- Miki Miyasato
- Taeka Sato
- Tappei Takada
- Kei Higuchi
- Hisanao Kishimoto
- Yoshiyuki Shirasaka
- Katsuhisa Inoue
Molecular Pharmaceutics (2023) 20 (1): 491.
- Sameen Zafar
- Muhammad Armaghan
- Khushbukhat Khan
- Nazia Hassan
- Javad Sharifi-Rad
- Solomon Habtemariam
- Marek Kieliszek
- Monica Butnariu
- Iulia-Cristina Bagiu
- Radu Vasile Bagiu
- William C. Cho
Biomedicine & Pharmacotherapy (2023) 165: 115039.
- Ji He
- Riya Biswas
- Piyush Bugde
- Jiawei Li
- Dong-Xu Liu
- Yan Li
Pharmaceutics (2022) 14 (5): 894.
- Matteo Duca
- Darren Wan-Teck Lim
- Vivek Subbiah
- Shunji Takahashi
- John Sarantopoulos
- Andrea Varga
- Joseph A. D'Alessio
- Tinya Abrams
- Qing Sheng
- Eugene Youchin Tan
- Maria Santos Rosa
- Juan Gonzalez-Maffe
- Janna Sand-Dejmek
- Claire Fabre
- Miguel Martin
Molecular Cancer Therapeutics (2022) 21 (4): 625.
- Bernadette de Rauglaudre
- Pascal Finetti
- David Jérémie Birnbaum
- Marc Lopez
- François Bertucci
- Emilie Mamessier
Molecular Cancer Therapeutics (2022) 21 (11): 1742.
- Inês Conde
- Ana Sofia Ribeiro
- Joana Paredes
Cells (2022) 11 (6): 934.
- Claudia Ceci
- Pedro Miguel Lacal
- Grazia Graziani
Pharmacology & Therapeutics (2022) 236: 108106.
- Kohei Matsuoka
- Mizuki Yamada
- Mitsuo Sato
- Kazuhide Sato
Biomedicines (2022) 10 (7): 1662.